Medicon Hellas Statistics
Total Valuation
Medicon Hellas has a market cap or net worth of EUR 10.56 million. The enterprise value is 11.75 million.
Market Cap | 10.56M |
Enterprise Value | 11.75M |
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | Jul 15, 2024 |
Share Statistics
Medicon Hellas has 4.42 million shares outstanding.
Current Share Class | 4.42M |
Shares Outstanding | 4.42M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.41% |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 8.04.
PE Ratio | 8.04 |
Forward PE | n/a |
PS Ratio | 0.58 |
PB Ratio | 0.57 |
P/TBV Ratio | 0.58 |
P/FCF Ratio | 10.61 |
P/OCF Ratio | 5.28 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.47, with an EV/FCF ratio of 11.80.
EV / Earnings | 8.60 |
EV / Sales | 0.65 |
EV / EBITDA | 3.47 |
EV / EBIT | 7.12 |
EV / FCF | 11.80 |
Financial Position
The company has a current ratio of 5.49, with a Debt / Equity ratio of 0.51.
Current Ratio | 5.49 |
Quick Ratio | 4.65 |
Debt / Equity | 0.51 |
Debt / EBITDA | 2.79 |
Debt / FCF | 9.48 |
Interest Coverage | 2.84 |
Financial Efficiency
Return on equity (ROE) is 6.78% and return on invested capital (ROIC) is 3.66%.
Return on Equity (ROE) | 6.78% |
Return on Assets (ROA) | 3.25% |
Return on Invested Capital (ROIC) | 3.66% |
Return on Capital Employed (ROCE) | 5.99% |
Revenue Per Employee | 115,442 |
Profits Per Employee | 8,702 |
Employee Count | 157 |
Asset Turnover | 0.57 |
Inventory Turnover | 1.70 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.90% in the last 52 weeks. The beta is 0.49, so Medicon Hellas's price volatility has been lower than the market average.
Beta (5Y) | 0.49 |
52-Week Price Change | -16.90% |
50-Day Moving Average | 2.21 |
200-Day Moving Average | 2.25 |
Relative Strength Index (RSI) | 58.06 |
Average Volume (20 Days) | 3,395 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicon Hellas had revenue of EUR 18.12 million and earned 1.37 million in profits. Earnings per share was 0.31.
Revenue | 18.12M |
Gross Profit | 12.88M |
Operating Income | 1.65M |
Pretax Income | 1.42M |
Net Income | 1.37M |
EBITDA | 2.93M |
EBIT | 1.65M |
Earnings Per Share (EPS) | 0.31 |
Balance Sheet
The company has 8.51 million in cash and 9.44 million in debt, giving a net cash position of -927,420 or -0.21 per share.
Cash & Cash Equivalents | 8.51M |
Total Debt | 9.44M |
Net Cash | -927,420 |
Net Cash Per Share | -0.21 |
Equity (Book Value) | 18.57M |
Book Value Per Share | 4.14 |
Working Capital | 17.74M |
Cash Flow
In the last 12 months, operating cash flow was 2.00 million and capital expenditures -1.01 million, giving a free cash flow of 995,407.
Operating Cash Flow | 2.00M |
Capital Expenditures | -1.01M |
Free Cash Flow | 995,407 |
FCF Per Share | 0.23 |
Margins
Gross margin is 71.07%, with operating and profit margins of 9.10% and 7.54%.
Gross Margin | 71.07% |
Operating Margin | 9.10% |
Pretax Margin | 7.81% |
Profit Margin | 7.54% |
EBITDA Margin | 16.16% |
EBIT Margin | 9.10% |
FCF Margin | 5.49% |
Dividends & Yields
This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 2.51%.
Dividend Per Share | 0.06 |
Dividend Yield | 2.51% |
Dividend Growth (YoY) | -60.82% |
Years of Dividend Growth | n/a |
Payout Ratio | 19.41% |
Buyback Yield | n/a |
Shareholder Yield | 2.58% |
Earnings Yield | 12.93% |
FCF Yield | 9.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on July 28, 2004. It was a forward split with a ratio of 1.1.
Last Split Date | Jul 28, 2004 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Medicon Hellas has an Altman Z-Score of 2.47. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.47 |
Piotroski F-Score | n/a |